MENAZIL
Live / Allowed — Published for opposition (as of 24 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 09 Jul 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99275322
- Mark type
- Stylized text
- Filed
- 09 Jul 2025
- Published for opposition
- 24 Mar 2026
- Attorney of record
- Joseph I. Hirsch
Goods and services
- Class 005 — Pharmaceuticals: Prescription pharmaceutical preparations having active pharmaceutical ingredients used to treat infectious diseases, cancer, cardiovascular diseases, psychiatric conditions, dermatological diseases, and respiratory conditions
Owner
- Newcastle Bioscience, LLC, Naples, FL, US
- Newcastle Bioscience, LLC, Naples, FL, US
Prosecution history
- 24 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Mar 2026 — PUBLISHED FOR OPPOSITION
- 18 Mar 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 02 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 02 Mar 2026 — EXAMINER'S AMENDMENT ENTERED
- 02 Mar 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 02 Mar 2026 — EXAMINERS AMENDMENT E-MAILED
- 02 Mar 2026 — EXAMINERS AMENDMENT -WRITTEN
- 31 Dec 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 31 Dec 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 31 Dec 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 05 Nov 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 05 Nov 2025 — NON-FINAL ACTION E-MAILED
- 05 Nov 2025 — NON-FINAL ACTION WRITTEN
- 27 Oct 2025 — ASSIGNED TO EXAMINER